Mutation profiling of 19 candidate genes in acute myeloid leukemia suggests significance of DNMT3A mutationsopen access
- Authors
- Shin, SY[Shin, Sang-Yong]; Lee, ST[Lee, Seung-Tae]; Kim, HJ[Kim, Hee-Jin]; Cho, EH[Cho, Eun Hae]; Kim, JW[Kim, Jong-Won]; Park, S[Park, Silvia]; Jung, CW[Jung, Chul Won]; Kim, SH[Kim, Sun-Hee]
- Issue Date
- 23-Aug-2016
- Publisher
- IMPACT JOURNALS LLC
- Keywords
- acute myeloid leukemia; mutation; next generation sequencing; DNMT3A
- Citation
- ONCOTARGET, v.7, no.34, pp.54825 - 54837
- Indexed
- SCIE
SCOPUS
- Journal Title
- ONCOTARGET
- Volume
- 7
- Number
- 34
- Start Page
- 54825
- End Page
- 54837
- URI
- https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/35529
- DOI
- 10.18632/oncotarget.10240
- ISSN
- 1949-2553
- Abstract
- We selected 19 significantly-mutated genes in AMLs, including FLT3, DNMT3A, NPM1, TET2, RUNX1, CEBPA, WT1, IDH1, IDH2, NRAS, ASXL1, SETD2, PTPN11, TP53, KIT, JAK2, KRAS, BRAF and CBL, and performed massively parallel sequencing for 114 patients with acute myeloid leukemias, mainly including those with normal karyotypes ( CN-AML). More than 80% of patients had at least one mutation in the genes tested. DNMT3A mutation was significantly associated with adverse outcome in addition to conventional risk stratification such as the European LeukemiaNet ( ELN) classification. We observed clinical usefulness of mutation testing on multiple target genes and the association with disease subgroups, clinical features and prognosis in AMLs.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.